VANGUARD GROUP INC - TONIX PHARMACEUTICALS HLDG C ownership

Back to all holdings Add to watchlist

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$1,435,060
+277.6%
2,427,778
+149.0%
0.00%–
Q4 2022$380,053
-17.2%
974,996
+13.6%
0.00%–
Q3 2022$459,000
-60.3%
858,416
+17.2%
0.00%–
Q2 2022$1,157,000–732,180–0.00%–
 Download
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,500,419$1,754,2630.26%
Virtu Financial LLC 188,075$730.01%
ACADIAN ASSET MANAGEMENT LLC 899,514$3490.00%
Renaissance Technologies 1,208,224$4710.00%
TWO SIGMA SECURITIES, LLC 55,484$21,6280.00%
JPMORGAN CHASE & CO 49,656$190.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,159$140.00%
Gradient Investments LLC 63$250.00%
Allworth Financial LP 1,000$3900.00%
VANGUARD GROUP INC 974,996$380,0530.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders